New antiarrhythmic drugs for the treatment of atrial fibrillation.
Castro
Antonio
A
Department of Heart Disease, S. Filippo Neri Hospital, Rome, Italy. antonello.castro@tin.it
Bianconi
Leopoldo
L
Santini
Massimo
M
D062365:Aminobenzoates / Q000627:therapeutic use; D000638:Amiodarone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy*; D019086:Bridged Bicyclo Compounds, Heterocyclic / Q000627:therapeutic use; D003521:Cyclopropanes / Q000627:therapeutic use; D000077764:Dronedarone; D006801:Humans; D006827:Hydantoins; D007093:Imidazoles / Q000627:therapeutic use; D048289:Imidazolidines; D010627:Phenethylamines / Q000627:therapeutic use; D010879:Piperazines / Q000627:therapeutic use; D013015:Sotalol / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use
D062365:Aminobenzoates; D000889:Anti-Arrhythmia Agents; D019086:Bridged Bicyclo Compounds, Heterocyclic; D003521:Cyclopropanes; D006827:Hydantoins; D007093:Imidazoles; D048289:Imidazolidines; D010627:Phenethylamines; D010879:Piperazines; D013449:Sulfonamides; C075113:ambasilide; C067192:ibutilide; C086123:azimilide; C059921:tedisamil; D013015:Sotalol; D000077764:Dronedarone; D000638:Amiodarone; C063533:dofetilide